Literature DB >> 2423308

The diagnosis and management of perforations of esophagus and pharynx sustained during intubation of neoplastic esophageal strictures.

K R Hine, M Atkinson.   

Abstract

Twenty-six esophageal and eight pharyngeal perforations sustained during palliative intubation of esophagogastric neoplasms have been reviewed. The majority of the tears were recognized either endoscopically or by the immediate development of subcutaneous emphysema. However, 15 perforations were first identified by radiology, and 10 of these 15 patients were initially asymptomatic. In the years 1976-1979 with conservative management, three patients of eight died from the perforation and none had a pneumothorax. From 1980 a more aggressive nonsurgical approach was used, and of 26 patients who sustained a perforation, there were six deaths before leaving hospital but only four deaths were directly related to the perforation and each of these had sustained a pneumothorax. Pharyngeal tears invariably did well with conservative management. Our experience favors conservative management for instrumental esophageal perforation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423308     DOI: 10.1007/bf01318687

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Rupture of the esophagus.

Authors:  W C SEALY
Journal:  Am J Surg       Date:  1963-04       Impact factor: 2.565

2.  Conservative treatment of stenosing diseases of the esophagus.

Authors:  K L PUESTOW
Journal:  Postgrad Med       Date:  1955-07       Impact factor: 3.840

3.  Perforation of the esophagus.

Authors:  B C Ghosh; K U Choudhry; E J Beattie
Journal:  Surg Gynecol Obstet       Date:  1972-11

4.  The management and prognosis of oesophageal perforation.

Authors:  F A Sandrasagra; T A English; B B Milstein
Journal:  Br J Surg       Date:  1978-09       Impact factor: 6.939

5.  Oesophageal perforation at fibreoptic gastroscopy.

Authors:  J Dawson; R Cockel
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-29

6.  The consequences and effectiveness of intubation in the palliation of dysphagia due to benign and malignant strictures affecting the oesophagus.

Authors:  A G Pfleiderer; P Goodall; G K Holmes
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

7.  The insertion of oesophagogastric tubes in malignant oesophageal strictures: endoscopy or surgery?

Authors:  A H Lishman; A W Dellipiani; H B Devlin
Journal:  Br J Surg       Date:  1980-04       Impact factor: 6.939

8.  Palliative dilation for dysphagia in esophageal carcinoma.

Authors:  H A Heit; L F Johnson; S R Siegel; H W Boyce
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

9.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  A L Ogilvie; M W Dronfield; R Ferguson; M Atkinson
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

10.  Tube introducer and modified Celestin tube for use in palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.

Authors:  M Atkinson; R Ferguson; G C Parker
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

View more
  4 in total

1.  The role of rigid oesophagoscopy in oesophageal carcinoma.

Authors:  A J Ritchie; K McManus; J McGuigan; H M Stevenson; J R Gibbons
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

2.  Instrumental perforations of the oesophagus and their management.

Authors:  K Moghissi; D Pender
Journal:  Thorax       Date:  1988-08       Impact factor: 9.139

3.  Treatment of a ruptured anastomotic esophageal stricture following bougienage with a Dacron-covered nitinol stent.

Authors:  W Heindel; A Gossmann; R Fischbach; O Michel; K Lackner
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

4.  Diagnostic rigid and flexible oesophagoscopy in carcinoma of the oesophagus: a comparison.

Authors:  A J Ritchie; J McGuigan; K McManus; H M Stevenson; J R Gibbons
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.